This announcement is a separate document:
共同药业：发行人及保荐机构关于湖北共同药业股份有限公司申请向不特定对象发行可转换公司债券的审核问询函之回复报告（豁免版修订稿）（2022年半年度财务数据更新）
Mutual Pharmaceutical: Issuer and Sponsor's Response Report to the Audit Enquiry Letter of Hubei Common Pharmaceutical Co., Ltd.'s Application for Issuance of Convertible Corporate Bonds to Unspecified Targets (Exempted Revised Draft) (Updated Financial Da
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated